{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:37:00Z","timestamp":1789663020938,"version":"4.0.1"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","award":["LOM AG-Klos, 7422116"],"award-info":[{"award-number":["LOM AG-Klos, 7422116"]}],"id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ZIB PhD program Hannover Medical School","award":["C.L. & M.K."],"award-info":[{"award-number":["C.L. & M.K."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Chlamydia trachomatis causes most bacterial sexually transmitted diseases worldwide. Different major outer membrane proteins (MOMPs) define various serovars of this intracellular pathogen: In women, D to L3 can cause urethritis, cervicitis, salpingitis, and oophoritis, and, thus, infertility. Protective immunity might be serovar-specific since chlamydial infection does not appear to induce an effective acquired immunity and reinfections occur. A better understanding of induced cross-serovar protection is essential for the selection of suitable antigens in vaccine development. In our mouse lung infection screening model, we evaluated the urogenital serovars D, E, and L2 in this regard. Seven weeks after primary infection or mock-infection, respectively, mice were infected a second time with the identical or one of the other serovars. Body weight and clinical score were monitored for 7 days. Near the peak of the second lung infection, bacterial load, myeloperoxidase, IFN-\u03b3, and TNF-\u03b1 in lung homogenate, as well as chlamydia-specific IgG levels in blood were determined. Surprisingly, compared with mice that were infected then for the first time, almost independent of the serovar combination used, all acquired parameters of disease were similarly diminished. Our reinfection study suggests that efficient cross-serovar protection could be achieved by a vaccine combining chlamydial antigens that do not include nonconserved MOMP regions.<\/jats:p>","DOI":"10.3390\/vaccines9080871","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T08:01:42Z","timestamp":1628236902000},"page":"871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chlamydia trachomatis Cross-Serovar Protection during Experimental Lung Reinfection in Mice"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-2942","authenticated-orcid":false,"given":"Christian","family":"Lanfermann","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kohn","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Laudeley","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rheinheimer","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8404-8789","authenticated-orcid":false,"given":"Andreas","family":"Klos","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"ref_1","unstructured":"Tan, M., Hegemann, J.H., and S\u00fctterlin, C. (2020). Chlamydia Biology: From Genome to Disease, Caister Academic Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/IAI.01244-13","article-title":"Hidden in plain sight: Chlamydial gastrointestinal infection and its relevance to persistence in human genital infection","volume":"82","author":"Rank","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/JCM.38.6.2292-2296.2000","article-title":"Urogenital Chlamydia trachomatis Serovars in Men and Women with a Symptomatic or Asymptomatic Infection: An Association with Clinical Manifestations?","volume":"38","author":"Rozendaal","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","first-page":"300","article-title":"Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial","volume":"95","author":"Hoenderboom","year":"2019","journal-title":"Sex. Transm. Infect."},{"key":"ref_5","unstructured":"(2016). WHO Guidelines for the Treatment of Chlamydia trachomatis, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/ijmr.IJMR_981_15","article-title":"Detection of Chlamydia trachomatis infections by polymerase chain reaction in asymptomatic pregnant women with special reference to the utility of the pooling of urine specimens","volume":"146","author":"Sethi","year":"2017","journal-title":"Indian J. Med. Res. Suppl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/sti.76.3.156","article-title":"Immunological basis of chlamydia induced reactive arthritis","volume":"76","author":"Gaston","year":"2000","journal-title":"Sex. Transm. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2005.04.034","article-title":"Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue","volume":"98","author":"Schlott","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"ref_10","unstructured":"(2021, January 15). World Health Organization Status of Elimination of Trachoma as a Public Health Problem. Available online: https:\/\/apps.who.int\/neglected_diseases\/ntddata\/trachoma\/trachoma.html."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmicb.2019.00070","article-title":"Seventy years of Chlamydia vaccine research\u2014Limitations of the past and directions for the future","volume":"10","author":"Phillips","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Schachter, J. (2014). Infection and Disease Epidemiology. Chlamydia, ASM Press.","DOI":"10.1128\/9781555818203.ch6"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/jb.169.9.3879-3885.1987","article-title":"Diversity of Chlamydia trachomatis major outer membrane protein genes","volume":"169","author":"Stephens","year":"1987","journal-title":"J. Bacteriol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/JCM.02308-09","article-title":"Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination","volume":"48","author":"Stevens","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: A first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1093\/molbev\/mss198","article-title":"Population genomics of chlamydia trachomatis: Insights on drift, selection, recombination, and population structure","volume":"29","author":"Joseph","year":"2012","journal-title":"Mol. Biol. Evol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e000313","DOI":"10.1099\/mgen.0.000313","article-title":"Chlamydia trachomatis: When the virulence-associated genome backbone imports a prevalence-associated major antigen signature","volume":"5","author":"Borges","year":"2019","journal-title":"Microb. Genomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mbo3.186","article-title":"All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function","volume":"3","author":"Becker","year":"2014","journal-title":"Microbiologyopen"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1172\/JCI119109","article-title":"An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells","volume":"98","author":"Kuo","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0092-8674(92)90296-O","article-title":"Mechanism of C. trachomatis attachment to eukaryotic host cells","volume":"69","author":"Zhang","year":"1992","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/21505594.2015.1111509","article-title":"Chlamydial polymorphic membrane proteins: Regulation, function and potential vaccine candidates","volume":"7","author":"Vasilevsky","year":"2016","journal-title":"Virulence"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"Chlamydia tracomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2015.02.055","article-title":"Outer membrane proteins preferentially load MHC class II peptides: Implications for a Chlamydia trachomatis T cell vaccine","volume":"33","author":"Karunakaran","year":"2015","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lanfermann, C., Wintgens, S., Ebensen, T., Kohn, M., Laudeley, R., Schulze, K., Rheinheimer, C., Hegemann, J.H., Guzm\u00e1n, C.A., and Klos, A. (2021). Prophylactic multi-subunit vaccine against chlamydia trachomatis: In vivo evaluation in mice. Vaccines, 9.","DOI":"10.3390\/vaccines9060609"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dutow, P., Wask, L., Bothe, M., Fehlhaber, B., Laudeley, R., Rheinheimer, C., Yang, Z., Zhong, G., Glage, S., and Klos, A. (2016). An optimized, fast-to-perform mouse lung infection model with the human pathogen Chlamydia trachomatis for in vivo screening of antibiotics, vaccine candidates and modified host-pathogen interactions. Pathog. Dis., 74.","DOI":"10.1093\/femspd\/ftv120"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/IAI.00357-13","article-title":"Animal models for studying female genital tract infection with chlamydia trachomatis","volume":"81","author":"Kalmar","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/15665240113136660078","article-title":"The Mouse Model of Chlamydia Genital Tract Infection: A Review of Infection, Disease, Immunity and Vaccine Development","volume":"14","author":"Andrew","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Verweij, S.P., Lanjouw, E., Bax, C.J., Quint, K.D., Oostvogel, P.M., D\u00f6rr, P.J., Pleijster, J., de Vries, H.J.C., Peters, R.P.H., and Ouburg, S. (2014). Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-3"},{"key":"ref_31","first-page":"1","article-title":"Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014\u20132017 from Austrian patients","volume":"9","author":"Stockinger","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/iai.41.2.865-868.1983","article-title":"Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington","volume":"41","author":"Kuo","year":"1983","journal-title":"Infect. Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fimmu.2021.626627","article-title":"Complement and Chlamydia psittaci: Non-myeloid derived C3 predominantly induces protective adaptive immune responses in mouse lung infection","volume":"12","author":"Kohn","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2021.580594","article-title":"Complement and Chlamydia psittaci: Early complement-dependent events are important for DC migration and protection during mouse lung infection","volume":"12","author":"Kohn","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_35","first-page":"e00543-16","article-title":"Update on Chlamydia trachomatis vaccinology","volume":"24","author":"Zhong","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/imm.12520","article-title":"A vaccine formulated with the major outer membrane protein can protect C3H\/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge","volume":"146","author":"Pal","year":"2015","journal-title":"Immunology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1128\/IAI.00841-15","article-title":"Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar, D","volume":"83","author":"Qu","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.chom.2018.04.002","article-title":"Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection","volume":"23","author":"Rother","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/iai.65.6.1993-1999.1997","article-title":"Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice","volume":"65","author":"Su","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1128\/iai.65.7.2876-2882.1997","article-title":"Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis","volume":"65","author":"Williams","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_42","first-page":"9","article-title":"Immune-mediated control of Chlamydia infection","volume":"10","author":"Roan","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/infdis\/jit640","article-title":"The Complement C3a Receptor Is Critical in Defense against Chlamydia psittaci in Mouse Lung Infection and Required for Antibody and Optimal T Cell Response","volume":"209","author":"Dutow","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1003707","DOI":"10.1371\/journal.ppat.1003707","article-title":"B Cells Enhance Antigen-Specific CD4 T Cell Priming and Prevent Bacteria Dissemination following Chlamydia muridarum Genital Tract Infection","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/eji.201948391","article-title":"Antibody, but not B-cell-dependent antigen presentation, plays an essential role in preventing Chlamydia systemic dissemination in mice","volume":"50","author":"Malaviarachchi","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2018.01981","article-title":"An Adaptive chlamydia trachomatis-specific IFN-\u03b3-producing CD4+ T cell response is associated with protection against chlamydia reinfection in women","volume":"9","author":"Bakshi","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/8\/871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:41:38Z","timestamp":1760164898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/8\/871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["vaccines9080871"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9080871","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}